APA (7th ed.) Citation

Meyer, G., Besse, B., Doubre, H., Charles-Nelson, A., Aquilanti, S., Izadifar, A., . . . Girard, P. (2018). Anti-tumour effect of low molecular weight heparin in localised lung cancer: A phase III clinical trial. The European respiratory journal, 52(4), . https://doi.org/10.1183/13993003.01220-2018

Chicago Style (17th ed.) Citation

Meyer, Guy, et al. "Anti-tumour Effect of Low Molecular Weight Heparin in Localised Lung Cancer: A Phase III Clinical Trial." The European Respiratory Journal 52, no. 4 (2018). https://doi.org/10.1183/13993003.01220-2018.

MLA (9th ed.) Citation

Meyer, Guy, et al. "Anti-tumour Effect of Low Molecular Weight Heparin in Localised Lung Cancer: A Phase III Clinical Trial." The European Respiratory Journal, vol. 52, no. 4, 2018, https://doi.org/10.1183/13993003.01220-2018.